KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Times Interest Earned: 2010-2025

Historic Times Interest Earned for Novavax (NVAX) over the last 16 years, with Sep 2025 value amounting to -$32.47.

  • Novavax's Times Interest Earned fell 2.64% to -$32.47 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.65, marking a year-over-year increase of 169.69%. This contributed to the annual value of -$12.40 for FY2024, which is 68.45% up from last year.
  • As of Q3 2025, Novavax's Times Interest Earned stood at -$32.47, which was down 277.29% from $18.32 recorded in Q2 2025.
  • Over the past 5 years, Novavax's Times Interest Earned peaked at $90.08 during Q1 2025, and registered a low of -$160.56 during Q4 2021.
  • For the 3-year period, Novavax's Times Interest Earned averaged around -$10.24, with its median value being -$31.64 (2024).
  • In the last 5 years, Novavax's Times Interest Earned plummeted by 1,058.13% in 2021 and then soared by 355.68% in 2025.
  • Quarterly analysis of 5 years shows Novavax's Times Interest Earned stood at -$160.56 in 2021, then spiked by 66.99% to -$53.01 in 2022, then increased by 15.88% to -$44.59 in 2023, then skyrocketed by 61.24% to -$17.28 in 2024, then fell by 2.64% to -$32.47 in 2025.
  • Its Times Interest Earned was -$32.47 in Q3 2025, compared to $18.32 in Q2 2025 and $90.08 in Q1 2025.